Home › Funds › BIT Capital GmbH › MLYS

BIT Capital GmbH position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

BIT Capital GmbH reported holding 90,100 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.11% of its reported portfolio and ranking #43 among its reported holdings. BIT Capital GmbH first reported this position in Q3 2026.

Latest position (Q3 2026)90.10K sh
Reported value held$2.26M
Portfolio Weight0.11%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BIT Capital GmbH's MLYS position evolved

BIT Capital GmbH first disclosed a stake in MLYS in Q3 2026 at 90,100 shares (US$2.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 90.10K $2.26M New

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has BIT Capital GmbH held MLYS?

BIT Capital GmbH has disclosed MLYS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is BIT Capital GmbH's current position in MLYS?

As of Q3 2026, BIT Capital GmbH holds 90.10K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $2.26M, representing 0.11% of its reported portfolio and ranking #43.

Has BIT Capital GmbH been buying or selling MLYS?

In the latest 13F filing (Q3 2026), BIT Capital GmbH newly opened its position in MLYS.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.